2019 novel coronavirus (2019-nCoV) outbreak: A new challenge
Author(s) -
Tommaso Lupia,
Silvia Scabini,
Simone Mornese Pinna,
Giovanni Di Perri,
Francesco Giuseppe De Rosa,
Silvia Corcione
Publication year - 2020
Publication title -
journal of global antimicrobial resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.917
H-Index - 26
eISSN - 2213-7173
pISSN - 2213-7165
DOI - 10.1016/j.jgar.2020.02.021
Subject(s) - covid-19 , outbreak , coronavirus , virology , betacoronavirus , coronavirus infections , pandemic , biology , medicine , infectious disease (medical specialty) , disease , pathology
Following the public-health emergency of international concern (PHEIC) declared by the World Health Organization (WHO) on 30 January 2020 and the recent outbreak caused by 2019 novel coronavirus (2019-nCoV) [officially renamed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] in China and 29 other countries, we aimed to summarise the clinical aspects of the novelBetacoronavirus disease (COVID-19) and its possible clinical presentations together with suggested therapeutic algorithms for patients who may require antimicrobial treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom